Viewing Study NCT02723695


Ignite Creation Date: 2025-12-24 @ 1:59 PM
Ignite Modification Date: 2026-04-08 @ 1:40 PM
Study NCT ID: NCT02723695
Status: UNKNOWN
Last Update Posted: 2016-03-30
First Post: 2016-03-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Perception and Equilibrium After Cochlear Implantation
Sponsor: Central Hospital, Nancy, France
Organization:

Study Overview

Official Title: Assessment of Perceptual and Postural Performances Following a Cochlear Implantation
Status: UNKNOWN
Status Verified Date: 2016-03
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: ORIENTIMPLANT
Brief Summary: The cochlear implant is an electrical hearing aid that restores the perception of surrounding sounds and speech intelligibility in profoundly deaf patients. During surgery, the labyrinthine break necessary for insertion into the cochlea of the implantable part may cause a malfunction of the vestibular system which can induce dizziness, balance and perception (of the gravitational vertical) disorders. Vestibular compensation and new sonic interactions could alter the balance control and the visual and postural spatial orientation perceptions.

The usual treatment includes the monitoring of the patient's quality of life, of the vestibular function and of hearing. This study adds an assessment of spatial orientation and of posture.
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: